Single Ascending Doses of HER-096 in Healthy Subjects

NCT05915247 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: HER-096
DRUG: Placebo

Sponsor

Herantis Pharma Plc.

Collaborators

[object Object]